Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05946031Phase 1Completed
Phase 1, randomised, open-label trial (2 arms), sponsored by Virginia Tech. Primary endpoints: Cigarette demand at 1 day and Nicotine/tobacco products substitution at 1 day. Started Dec 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05946031.